Trial intelligence / Profile preview

Victoza vs Lantus in type 2 diabetes after hospital discharge

NCT01919489Phase 4Completed

Sponsor
Emory University
Start
Mar 2014
Primary completion
Aug 2020
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Emory University. Started Mar 2014; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01919489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01919489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call